Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...

The trial evaluated the effectiveness of AstraZeneca’s camizestrant, an investigational next-generation oral selective ...

Optimal lead follicle size of 19 to 23 mm was associated with improved clinical pregnancy rates among patients undergoing IUI.

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

such as injectable fulvestrant – sold by AZ as Faslodex and the only SERD approved for breast cancer – or aromatase inhibitors like letrozole, anastrozole, or exemestane. For the overall group ...

Breast cancer remains the most common cancer among women globally, and Germany stands at the forefront of offering advanced and effective treatment options. Through a combination of high medical ...

I am a baby boomer who was born in 1949. I was vaccinated against polio as soon as it was available, and I was most likely ...

Inflammatory breast cancer (IBC) is an uncommon and aggressive type of breast cancer. It can cause the breast to appear red and swollen, giving the appearance of inflammation. In the United States, ...